5 Matching Annotations
  1. Sep 2024
  2. www.sciencedirect.com www.sciencedirect.com
    The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
    1
    1. scibot 25 Sep 2024
      RRID:CVCL_0262

      DOI: 10.1016/j.cell.2019.07.031

      Resource: (ATCC Cat# CRL-2882, RRID:CVCL_6831)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_6831

      What is this?
      RRID:CVCL_6831 RRID:CVCL_0262 RRIDCUR:Incorrect
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S009286741930830X
  3. Aug 2023
  4. 52.53.155.43 52.53.155.43
    L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab
    2
    1. scibot 18 Aug 2023
      RRID:CVCL_6831

      DOI: 10.1016/j.xcrm.2023.101142

      Resource: (ATCC Cat# CRL-2882, RRID:CVCL_6831)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_6831

      What is this?
      RRID:CVCL_6831
    2. scibot 10 Aug 2023
      RRID:CVCL_6831

      DOI: 10.1016/j.xcrm.2023.101142

      Resource: (ATCC Cat# CRL-2882, RRID:CVCL_6831)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_6831

      What is this?
      RRID:CVCL_6831
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/bb31ad2b14838f5cede2aca897c595e2febf2f88/PIIS2666379123002951-html.html
  5. Jul 2023
  6. www.nature.com www.nature.com
    MLK4 promotes glucose metabolism in lung adenocarcinoma through CREB-mediated activation of phosphoenolpyruvate carboxykinase and is regulated by KLF5
    1
    1. scibot 06 Jul 2023
      RRID: CVCL_6831

      DOI: 10.1038/s41389-023-00478-y

      Resource: (ATCC Cat# CRL-2882, RRID:CVCL_6831)

      Curator: @anisehay

      SciCrunch record: RRID:CVCL_6831

      What is this?
      RRID:CVCL_6831
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41389-023-00478-y
  7. Sep 2020
  8. pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
    Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer
    1
    1. scibot 16 Sep 2020
      RRID:CVCL_6831

      DOI: 10.7554/eLife.58204

      Resource: (ATCC Cat# CRL-2882, RRID:CVCL_6831)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_6831

      What is this?
      RRIDCUR:Validated RRID:CVCL_6831
    Visit annotations in context

    Tags

    Annotators

    URL

    pubmed.ncbi.nlm.nih.gov/32897190/